Would you fly with this pilot? DOI
Eddie D Davenport

Heart, Journal Year: 2025, Volume and Issue: unknown, P. heartjnl - 325907

Published: April 15, 2025

Language: Английский

Exercise across the cardiovascular continuum: expanding perspectives on its key role in contemporary clinical practice DOI Creative Commons
Eduardo M. Vilela, Marco Oliveira, Madalena Teixeira

et al.

Porto Biomedical Journal, Journal Year: 2025, Volume and Issue: 10(2)

Published: March 1, 2025

Language: Английский

Citations

0
The Cardiovascular Care of the Pediatric Athlete DOI
Peter N. Dean,

Julie A. Brothers,

Kristin M. Burns

et al.

Journal of the American College of Cardiology, Journal Year: 2025, Volume and Issue: 85(13), P. 1434 - 1454

Published: April 1, 2025

Language: Английский

Citations

0
Acquired Genotype‐Positive Long QT Syndrome After Pediatric Heart Transplantation DOI Creative Commons

Nicholas V. Barresi,

Jessica Sebastian,

Gaurav Arora

et al.

Pediatric Transplantation, Journal Year: 2025, Volume and Issue: 29(3)

Published: April 2, 2025

ABSTRACT Background Congenital long QT syndrome (LQTS) is rare but significant, as it carries a risk for ventricular arrhythmias and sudden cardiac death. Its diagnosis can be made clinically by serial ECGs, ambulatory ECG monitoring, exercise stress testing; however, genetic testing confirmatory in the majority of cases. Methods Here, we describe case phenotype‐positive LQTS 6‐year‐old heart transplant recipient, confirmed 5 years after transplantation to genotype‐positive thus “acquired” from transplanted heart. Results Recognition persistently prolonged QTc interval on recipient's ECGs led monitoring testing—both which were suspicious LQTS. Ultimately, evaluation biopsy obtained resulted positive KCNQ1 pathogenic variant associated with Type 1 Conclusion persistent, otherwise unexplained, abnormalities prompt analysis allograft, leading potential life‐saving channelopathy.

Language: Английский

Citations

0
Antiplatelet and Anticoagulation Therapy in Athletes: A Cautious Compromise… If Possible! DOI Creative Commons
Flavio D’Ascenzi, Gianfranco Manfredi,

Vincenzo Minasi

et al.

Journal of Cardiovascular Development and Disease, Journal Year: 2025, Volume and Issue: 12(4), P. 151 - 151

Published: April 10, 2025

Antiplatelet and anticoagulation therapy are commonly used in the general population sometimes athletes experiencing cardiovascular disorders. In these cases, treatment has to be tailored according individual bleeding thrombotic risk profile, also considering intrinsic of sports activities when advising for eligibility competitive sports. athletes, it is necessary pre-assess risk, not only personal (usually low athletes) but type sport athlete would like practice, with careful consideration where traumatic collisions highly likely. Additionally, non-steroidal anti-inflammatory drugs among antiplatelet may further increase risk. Therefore, selected default approach antithrombotic could personalized. This review discusses clinical management challenges under or therapy, focusing on risks practice indications disqualification.

Language: Английский

Citations

0
Would you fly with this pilot? DOI
Eddie D Davenport

Heart, Journal Year: 2025, Volume and Issue: unknown, P. heartjnl - 325907

Published: April 15, 2025

Language: Английский

Citations

0